PIL - Co-codamol 30 mg/500 mg Effervescent Tablets: Change history
View Patient Information Leaflet (PIL - Co-codamol 30 mg/500 mg Effervescent Tablets)
Last updated on this site: 04 Aug 2025
Description of update: To update sections 4.8, 5.1 and 5.2 of the SmPC to bring in line with the Reference product Solpadol 30mg/500mg Caplets. Consequently, the PIL has been updated. Additional updates include editorial and QRD updates to the PIL.
Date of approval: 29/07/2025
PIL sections updated: Introduction, 2, 4, 5 and 6
Last updated on this site: 04 Aug 2025
Description of update: To update sections 4.8, 5.1 and 5.2 of the SmPC to bring in line with the Reference product Solpadol 30mg/500mg Caplets. Consequently, the PIL has been updated. Additional updates include editorial and QRD updates to the PIL.
Date of approval: 29/07/2025
PIL sections updated: Introduction, 2, 4, 5 and 6
-
Changes: (Updated: 04 Aug 2025)
Description of update: To update sections 4.8, 5.1 and 5.2 of the SmPC to bring in line with the Reference product Solpadol 30mg/500mg Caplets. Consequently, the PIL has been updated. Additional updates include editorial and QRD updates to the PIL.
Date of approval: 29/07/2025
PIL sections updated: Introduction, 2, 4, 5 and 6
-
Changes: (Updated: 19 May 2023)
Variation Description: 1) To update section 4.4 of the SmPC and section 2 of the PIL to include cautionary warning to patients with myasthenia gravis.
2) To update section 4.4 of the SmPC and section 2 of the PIL to highlight the drug interaction between co-codamol and antidepressants.
3) Typographical amendments to the PIL.
PIL sections updated- Heading, 2, 4, 5 and 6.
-
Changes: (Updated: 22 Sep 2022)
initial upload